A2DMQY Cronos Group Inc

Cronos Group Inc. Announces Final Settlement Agreements

Cronos Group Inc. Announces Final Settlement Agreements

TORONTO, Oct. 24, 2022 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) today announced that it has reached final settlement agreements with each of the U.S. Securities and Exchange Commission (the “SEC”) and the Staff of the Ontario Securities Commission (the “OSC”) that resolve those regulators’ investigations regarding the previously disclosed restatements by the Company of its financial statements for the first three quarters of 2019 and the second quarter of 2021.

“We are pleased to have resolved these matters,” said Mike Gorenstein, Chairman, President and Chief Executive Officer of Cronos. “Important steps have been taken to strengthen our internal controls, and we are committed to continuing this work.”

SEC Settlement

On October 24, 2022, the SEC issued an Order Instituting Cease-and-Desist Proceedings Pursuant to Section 8(a) of the U.S. Securities Act of 1933 (the “Securities Act”) and Section 21(c) of the U.S. Securities Exchange Act of 1934 (the “Exchange Act”), Making Findings, and Imposing a Cease-and-Desist Order (the “SEC Settlement Order”) resolving the SEC’s investigation of the restatements by the Company described above.

The Company has agreed to settle with the SEC, without admitting or denying the allegations described in the SEC Settlement Order. The SEC Settlement Order fully and finally disposes of the investigation of the Company by the SEC into the restatements without the payment of any civil penalty or other amount.

The SEC Settlement Order requires the Company to cease and desist from committing or causing any violations and any future violations of certain provisions of the U.S. federal securities laws. Additionally, the Company agreed to certain undertakings which include, among other things, retaining a qualified independent consultant (the “Consultant”) to engage in a review of, and make recommendations with respect to, certain of the Company’s internal accounting controls and internal control over financing reporting.

OSC Settlement

On October 24, 2022, the Ontario Capital Markets Tribunal approved a settlement agreement (the “OSC Settlement Agreement”) between the Company and the staff of the OSC, resolving the OSC’s investigation of the restatements by the Company described above.

Pursuant to the terms of the OSC Settlement Agreement, which fully and finally disposes of the investigation of the Company by the OSC, Cronos agreed to pay a total of C$1.34 million to fully settle the matter and acknowledged that it had not complied with certain requirements under the Securities Act (Ontario) in connection with the filing of interim financial reports in the manner set out therein. Additionally, the Company agreed to retain the Consultant on substantially the same terms as were required by the SEC pursuant to the SEC Settlement Order.

Additional Information

As a result of the SEC Settlement, the Company will be unable to rely on the private offering exemptions provided by Regulations A and D under the Securities Act for a period of five years; lose its status as a well-known seasoned issuer for a period of three years; and be unable to rely on the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995 for a period of three years.

For more information regarding the SEC Settlement Order and the OSC Settlement Agreement, please see the Company’s Form 8-K filed on EDGAR at /edgar and on the Company’s SEDAR profile at

About Cronos

Cronos is an innovative global cannabinoid company committed to building disruptive intellectual property by advancing cannabis research, technology and product development. With a passion to responsibly elevate the consumer experience, Cronos is building an iconic brand portfolio. Cronos’ diverse international brand portfolio includes Spinach®, PEACE NATURALS®, Lord Jones®, Happy Dance® and PEACE+®. For more information about Cronos and its brands, please visit: thecronosgroup.com.

Cronos Contact

Shayne Laidlaw

Tel: (416) 504-0004



EN
24/10/2022

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Cronos Group Inc

 PRESS RELEASE

Cronos Group Inc. to Hold 2025 Fourth Quarter and Full-Year Earnings C...

Cronos Group Inc. to Hold 2025 Fourth Quarter and Full-Year Earnings Conference Call on February 26, 2026 TORONTO, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) will hold its 2025 fourth quarter and full-year earnings conference call on Thursday, February 26, 2026 at 8:30 a.m. ET. Cronos’ senior management team will discuss the Company’s financial results and will be available for questions from the investment community after prepared remarks. To attend the conference call or webcast, participants should register online at . To...

 PRESS RELEASE

Cronos Group משיקה את מותג הפרימיום Lord Jones® בישראל ומקדמת אסטרטגי...

Cronos Group משיקה את מותג הפרימיום Lord Jones® בישראל ומקדמת אסטרטגיית מוצרים גלובלית חוצת גבולות טורונטו, Feb. 02, 2026 (GLOBE NEWSWIRE) --  חברת Cronos Group Inc. (NASDAQ: CRON; TSX: CRON) (“קרונוס” או “החברה”), מהחברות הגלובליות המובילות בעולם הקנאבינואידים, הודיעה היום על השקת מותג הקנאביס הפרימיום Lord Jones® בישראל. ההשקה מהווה אבן דרך משמעותית באסטרטגיית המוצרים חוצת הגבולות של קרונוס, ומרחיבה את פורטפוליו המותגים הבינלאומי והמוערך של החברה לאחד משווקי הקנאביס המתקדמים, המקצועיים ומבעלי הסטנדרטים הגבוהים בעולם. השלב הראשון של ההשקה כולל חמישה זני תפרחות פרימיום, שגודלו בגידול...

 PRESS RELEASE

Cronos Group Launches Premium Lord Jones® Brand in Israel, Advancing B...

Cronos Group Launches Premium Lord Jones® Brand in Israel, Advancing Borderless Product Strategy TORONTO, Feb. 02, 2026 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON; TSX: CRON) (“Cronos” or the “Company”), a leading global cannabinoid company, today announced the launch of its Lord Jones® premium cannabis brand in Israel. The introduction marks a significant milestone in Cronos’ borderless product strategy, expanding the Company’s globally recognized brand portfolio into one of the most advanced and discerning medical cannabis markets in the world. The first phase of the launch br...

 PRESS RELEASE

Cronos to enter the Netherlands with acquisition of Europe’s largest a...

Cronos to enter the Netherlands with acquisition of Europe’s largest adult-use cannabis company Cronos to acquire CanAdelaar for up-front cash consideration of US$67.0M1 plus cash earnout of 0.5x normalized EBITDA in 2026 and 2027 Up-front consideration represents approximately 1.4x CanAdelaar LTM revenue and 2.4x LTM EBITDA2 Will give Cronos #1 market share3 in the largest adult-use cannabis market in Europe Enables borderless product strategy, leveraging investments in genetics, R&D, and product development TORONTO, Dec. 09, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON)...

 PRESS RELEASE

Cronos Launches Premium Lord Jones Live Resin Fusions™ in Canada

Cronos Launches Premium Lord Jones Live Resin Fusions™ in Canada TORONTO, Nov. 25, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”), an innovative global cannabinoid company, today announced is expanding its portfolio for its Lord Jones® brand with new innovations designed to enhance its lineup of premium cannabis products in the Canadian market. The new Lord Jones Live Resin Fusions™ pre-rolls combine top-tier craftsmanship with exceptional cannabis genetics, reflecting the brand’s continued dedication to quality and refinement. The Lord ...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch